Scott M. Coiante
SVP, Chief Financial Officer · LEXICON PHARMACEUTICALS, INC.
Individual
- 2026
- Mar 3, 2026
- 2
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Scott M. Coiante files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Invus Global Management, LLC - $2.00M in LXRX purchases and sales in the last 12 months
- Raymond Debbane - $723K in LXRX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Scott M. Coiante?
Scott M. Coiante is a corporate insider, tracked as SVP, Chief Financial Officer of LEXICON PHARMACEUTICALS, INC. (LXRX). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Scott M. Coiante last file a Form 4?
The most recent primary Form 4 on record is dated 3 March 2026, one of 2 filings going back to 2026.
